Milestone payment triggered by the initiation of a Phase 2 clinical trial in Alzheimer’s disease with MK-1167, an α7 nicotinic…
Bioxodes raises €2.7 million from existing investors in Series A extensionInterim data from BIRCH intracerebral hemorrhage (ICH) Phase 2a trial…
BRAINTREE, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously…
STAMFORD, Conn., Feb. 11, 2025 /PRNewswire/ -- Neuvotion, Inc. is an early-stage medical device company developing AI-driven neuromodulation technologies and…
New certifications follow Dräger's previous ATO certification for a critical care ventilator Dräger Evita V800/V600 and Babylog VN800 family of…
Investment Powers the Debut of Pyxa: A Groundbreaking Platform for 3D Spatial Biology Research BOSTON, Feb. 11, 2025 /PRNewswire/ -- Stellaromics,…
Collaboration Aims to Develop First Intranasal Therapy for Mild Traumatic Brain Injury Aka Concussion, Establishing a Comprehensive Test-to-Treat PlatformSARASOTA, Fla.…
SEATTLE and VANCOUVER, British Columbia, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical…
Collaboration to provide Firefly with the technical resources to help further unleash the power of its FDA-cleared BNA™ platform For…
MIAMI, Feb. 10, 2025 /PRNewswire/ -- The Digital Safety Alliance (DSA) is proud to celebrate its one-year anniversary with the…